Caricamento...
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Lenalidomide is an integral, yet evolving, part of current treatment pathways for both transplant-eligible and transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM). It is approved in combination with dexamethasone as first-line therapy for transplant-ineligible patients with N...
Salvato in:
| Pubblicato in: | Ann Hematol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340649/ https://ncbi.nlm.nih.gov/pubmed/32296915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04023-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|